Evidence from the acceleration of cytochrome c reduction for the formation of ascorbate free radical by dopamine β-monooxygenase  by Ljones, Torbjørn & Skotland, Tore
Volume 108, number 1 FEBS LETTERS December 1979 
EVIDENCE FROM THE ACCELERATION OF CYTOCHROME c REDUCTION FOR THE 
FORMATIlON OF ASCORBATE FREE RADICAL BY DOPAMINE fl-MONOOXYGENASE 
Torbjdrn LJONES and Tore SKOTLAND 
Department of Biochemistry, University of Bergen, Arstadveien 19, N-5000 Bergen, Norway 
Received 23 August 1979 
1. Introduction 
Dopamine /3-monooxygenase (dopamine /3-hydrox- 
ylase; EC 1.14.17.1) catalyzes the reaction: 
Dopamine t ascorbate t Oa + 
noradrenaline t dehydroascorbate t Hz0 
This is believed to be the physiologically important 
reaction in mammalian tissues, but the purified 
enzyme is also an efficient catalyst for similar 
hydroxylations with a number of alternative sub- 
strates. Dopamine can be replaced by several other 
derivatives of phenylethylamine, with tyramine 
frequently being used for assays of the enzyme. 
Ascorbate can be replaced by other two-electron 
(2 e-) donors, such as catechol, or by the oneelec- 
tron (1 e-) donor Fe(CN)z -. The path of electron 
transfer is believed to involve the enzyme-bound 
copper (reviewed [ 11). 
Classification of ascorbate as a 2 e-donor in. 
enzymic oxidations describes the overall stoichiometry 
correctly. It leaves open, however, the question of 
whether: 
(i) Each ascorbate ion transfers 2 e- to the enzyme 
and is released as dehydroascorbate; or 
(ii) Each ascorbate ion transfers 1 e- and is released 
as the unstable ascorbate free radical (semidehydro- 
ascorbate), followed by nonenzymic dismutation 
of two radicals to give one ascorbate and one 
dehydroascorbate. 
Most discussions of the mechanism of dopamine 
fl-monooxygenase have assumed alternative (i), but 
we have discussed alternative (ii) [ 11. Compelling 
evidence for 1 e- mechanisms (alternative (ii)) in the 
cases of ascorbate oxidation by ascorbate oxidase 
and by peroxidase has been presented [2]. The experi- 
mental methods used were EPR spectroscopy [3] and 
a scavenger method which employed oxidized cyto- 
chrome c as the scavenger of radicals [4]. Ascorbate 
free radical reduces cytochrome c more rapidly than 
the fully reduced ascorbate, and hence an accelera- 
tion of cytochrome c reduction upon the addition of 
oxidizing enzyme was interpreted as evidence for free 
radical formation in the enzymic oxidations. 
Although the question of 1 e- or 2 e- transfer in 
the oxidation of ascorbate by dopamine &mono- 
oxygenase must be answered for correct interpreta- 
tion of the kinetics and mechanism of this enzyme, 
the problem had not yet been addressed experimen- 
tally. We now report evidence obtained with the cyto- 
chrome c scavenger method that dopamine /3-mono- 
oxygenase also employs a 1 e- mechanism, releasing 
ascorbate free radical as the product of enzymic 
oxidation. Our experimental evidence includes mea- 
surements with ascorbate oxidase for the purpose of 
comparing with a standard reaction [2 1, and the 
results reveal close correspondence between these 
two enzymes in the cytochrome c reduction assay. 
2. Materials and methods 
The water-soluble form of dopamine p-mono- 
oxygenase was purified from bovine adrenal medulla 
[5,6]. Cytochrome c, type VI from horse heart, 
catalase from bovine liver (C-100), and superoxide 
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dismutase, type I from bovine blood, were obtained 
from Sigma. Ascorbate oxidase from squash was 
obtained from Boehringer Mannheim. Fusaric acid 
(5-butyl picolinic acid) was obtained from ICN Pharma- 
ceuticals. Absorbance changes were measured with a 
Cary 2 19 recording spectrophotometer. Rates were 
calculated using these values for extinction coefficients: 
E for ascorbate (pH 6.0) at 265 nm: 14 mM_’ . cm-’ 
[7], and Ae (reduced minus oxidized) for cytochrome c 
at 550 nm: 22 mM_’ . cm-’ [8]. 
3. Results and discussion 
Addition of dopamine fl-monooxygenase markedly 
accelerates the reduction of ferricytochrome c in the 
presence of ascorbate (fig.1). The time-course of this 
reduction (b) coincides with the time-course of 
ascorbate oxidation (a) i.e., the reduction of cyto- 
chrome c ceases when all the ascorbate has been 
oxidized in the enzyme reaction. A similar experi- 
ment with ascorbate oxidase is also depicted in fig.1, 
which reveals that the ratios between cytochrome c 
reduction and ascorbate oxidation are quite similar 
for these two enzymes under our experimental con- 
ditions. The variation in shapes between the time- 
courses for the two enzymes is explained by their 
different Michaelis constants for ascorbate. 
Experiments similar to that in fig.1 were performed 
with varying concentrations of oxidizing enzymes 
(fig.2). The results again clearly indicate the same 
ratios between cytochrome c reduction and ascorbate 
oxidation for dopamine fl-monooxygenase and 
ascorbate oxidase. The data also give a reasonably 
good fit to the expected linear relationship between 
the rate of cytochrome c reduction and the square 
root of the rate of ascorbate oxidation [4]. This rela- 
tionship is predicted because of the second-order ate 
law for the radical dismutation, and because dismuta- 
tion is the dominant pathway for removal of the 
radical at our reaction conditions. The data in fig.1 
indicate that only 1.7% of the radical formed reacts 
with cytochrome c. The % reacting with cytochrome c 
Fig.1. Ascorbate oxidation and cytochrome c reduction in 
the presence of dopamine p-monooxygenase or ascorbate 
oxidase. Reaction mixtures contained: 10 mM 2(Nmorpho- 
lino)-ethanesulfonic acid (MES), 1 mM tyramine, 2 PM 
CuSO,, 80 mM sodium acetate (an activator of dopamine 
p-monooxygenase), 8 PM ferricytochrome c, 125 @/ml 
catalase, 50 PM ascorbate. Total vol. 1 ml; temp. 25°C; 
pH 6.0; lightpath 1 cm. The time courses depict ascorbate 
oxidation measured at 265 nm (a) and cytochrome c reduc- 
tion measured at 550 nm in the presence (b) or absence (c) 
of oxidizing enzyme. Enzymes used for curves (a,b): 
52 gg/ml of dopamine p-monooxygenase, unbroken curves; 
0.23 units/ml of ascorbate oxidase, broken curves where 
they do not coincide with the curves for dopamine p-mono- 
oxygenase. The ascorbate oxidation in the absence of oxidizing 
enzymes was 9% of the oxidation in (a). 
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Fig.2. The relationship between the initial rates of cyto- 
chrome c reduction and ascorbate oxidation in the presence 
of different amounts of dopamine p-monooxygenase (0) or 
ascorbate oxidase (0). Experimental conditions were as 
described in the legend to fig.1. The values for the highest 
rates of ascorbate oxidation for both enzymes were taken 
from fig.1. The values on the ordinate are given as the differ- 
ences between the rates of cytochrome c reduction in the 
presence and absence of oxidizing enzyme. 
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could be increased by using higher levels of cyto- 
chrome c, but this would also increase experimental 
error due to the higher rate of nonenzymic reaction 
between ascorbate and cytochrome c. 
The rate of cytochrome c reduction in the absence 
of oxidizing enzy-are (fig.l(c)) was rather high, partly 
due to the inclusion of 2 E.IM CuSO4 in the reaction 
mixture. The CuS04 was nevertheless retained to 
give maximal stimulation of dopamine p-mono- 
oxygenase catalysis 191. 
Fusaric acid, an inhibitor of dopamine p-mono- 
oxygenase, at 30 PM completely abolished the effect 
of the enzyme on both ascorbate oxidation and cyto- 
chrome c reduction. 
To investigate the possibility that cytochrome c 
reduction went by way of superoxide anion rather 
than ascorbate free radical, we included a control 
experiment with superoxide dismutase. Addition of 
this enzyme at 200 pg/ml to a reaction mixture other- 
wise identical to that described in the legend to fig.1, 
gave no inhibition of the dopamine fl-monooxygenase 
stimulated reduction of cytochrome c. 
From the results in fig.1 and 2, together with the 
established evidence for ascorbate free radical as the 
product in the ascorbate oxidase reaction [2-41, we 
conclude that dopamine P-monooxygenase also 
oxidizes ascorbate to the free radical. The final prod- 
uct, dehydroascorbate, must then arise from non- 
enzymic dismutation of the free radical. 
A small EPR contribution, attributed to ascorbate 
free radical, has been observed in frozen mixtures of 
dopamine S-monooxygenase and ascorbate [lo]. The 
contribution was, however, smaller in complete 
hydroxylation mixtures, and thus its significance to 
enzymically formed ascorbate free radical seems 
doubtful. 
Several alternatives for the involvement of the 
enzyme-bound copper in dopamine /3-monooxygenase 
catalysis have been presented. It was proposed [ 11,121 
that reduction of 2 Cu/active site by 1 ascorbate 
molecule is the first step, followed by release of dehy- 
droascorbate. However, we have reported evidence 
in conflict with this type of mechanism [9,13-l 51, 
leading us to propose that reduction by ascorbate of 
1 Cu/active site is the first step, followed by transfer 
of this first electron to bound 0s before the same 
copper atom accepts a second electron [l]. The evi- 
dence for 1 e- transfer and production of ascorbate 
free radical certainly presents no conflict with our 
proposed type of mechanism. The alternative mecha- 
nism with 2 Cu/active site is, however, more in line 
with the mechanism of tyrosinase, which contains 
2 Cu/active site [16] and is a 2 e- transfer enzyme, 
producing the fully oxidized forms rather than the 
free radical (semiquinone) forms of its catechol sub- 
strates [17]. 
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